Related Experiment Video
Updated: Jul 12, 2025

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Glucagonoma-induced Dilated Cardiomyopathy in a Young Woman
Jennifer Lourdes Ng1, Lee Matthew Ponce1, Gabriel Jasul1
1Section of Endocrinology, Diabetes and Metabolism, Department of Medicine St. Luke's Medical Center, Quezon City, Philippines 1112.
Abstract:
A 27-year-old woman presented with an epigastric mass, accompanied by emesis and weight loss. An abdominal computed tomography (CT) scan showed a pancreatic head-body mass and liver metastasis. Biopsy revealed well-differentiated pancreatic neuroendocrine tumor, grade 3. Chromogranin and synaptophysin stains were positive, with a Ki-67 index of 33.6%. Increased frequency of episodic emesis with incomprehensible speech and right-sided weakness prompted admission. A cranial magnetic resonance imaging (MRI) scan showed a subacute cerebrovascular infarct. Serum glucagon was markedly elevated. On the third hospital day, neurologic symptoms progressed, with repeat cranial MRI demonstrating acute lacunar infarcts. Two-dimensional echocardiography was consistent with dilated cardiomyopathy. Because of her fragile condition, she was not a candidate for surgery and chemotherapy. She was treated with long-acting octreotide every 4 weeks for a total of 10 doses. Posttreatment, a 2-dimensional echocardiogram and an abdominal CT scan showed no significant change. We report a rare case of glucagonoma with associated prominently dilated cardiomyopathy and ischemic stroke.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Hypoglycemia and Glucagon
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Diabetes Mellitus: Type 2 and Gestational
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification

